Business Context and Reporting Period
Company: Ingredion Incorporated (INGR)
Filing Type: Form 8-K (Current Report)
Date of Report: June 8, 2026
Event: Entry into a Material Definitive Agreement to acquire Tate & Lyle PLC.
On June 8, 2026, Ingredion announced a recommended all-cash offer to acquire the entire issued and to be issued ordinary share capital of Tate & Lyle PLC. The transaction is intended to be implemented via a court-sanctioned scheme of arrangement under UK law, with a fallback option for a takeover offer.
Key Financial Metrics and Transaction Terms
- Offer Price: 595 pence in cash per Tate & Lyle share.
- Total Cash Consideration: Approximately £2.7 billion (approx. $3.6 billion based on June 5, 2026 exchange rates).
- Permitted Dividends: Tate & Lyle shareholders may receive a final dividend of up to 13.2 pence per share (FY ended March 31, 2026) and an interim dividend of up to 6.8 pence per share (period ending September 30, 2026).
- Financing Facility: A 364-day senior unsecured bridge term loan credit facility of $4.225 billion secured with JPMorgan Chase Bank, N.A.
- Bridge Loan Covenants:
- Maximum leverage ratio: 3.5 to 1.0 (increasing to 4.0 to 1.0 for four quarters post-acquisition).
- Minimum interest coverage ratio: 3.5 to 1.0.
- Interest margins: Base rate + 0.125% to 0.375% or SOFR + 1.125% to 1.375%.
Note: This filing does not provide Ingredion's standalone revenue, profit, cash flow, or existing debt levels as of the reporting date.
Material Changes and Conditions
The filing details the execution of several definitive agreements on June 8, 2026:
- Co-operation Agreement: Tate & Lyle has agreed to cooperate to satisfy regulatory conditions.
- Irrevocable Undertakings:
- Supporting Shareholder: Huber Equity Corporation (approx. 16.8% ownership) agreed to vote in favor of the scheme.
- Directors: Tate & Lyle directors holding shares (approx. 0.3% ownership) agreed to vote in favor.
- Conditions to Completion:
- Shareholder approval (75% in value, majority in number).
- Sanction by the High Court of Justice in England and Wales.
- Satisfaction or waiver of material antitrust conditions.
- Completion by the "Long Stop Date" of December 8, 2027 (extendable to June 8, 2028).
Outlook, Risks, and Management Commentary
Expected Timeline: Completion is expected in the second half of 2027, subject to conditions.
Risks and Contingencies:
- Regulatory Approval: The transaction is subject to antitrust clearance and UK court sanction.
- Financing Risk: While there is no financing condition to the acquisition itself, the bridge loan contains covenants and events of default that could impact liquidity if breached.
- Competing Offers: Irrevocable undertakings from the supporting shareholder and directors may lapse if a competing offer exceeds the current consideration by 10% or more.
- Integration Risks: Management notes risks regarding the diversion of attention from ongoing operations and the ability to realize anticipated synergies.
- Market Risks: Exposure to raw material price fluctuations (corn), geopolitical tensions, supply chain interruptions, and foreign exchange rates.
Investor Verification Checklist
- Verify the final exchange rate impact on the $3.6 billion total consideration at the time of closing.
- Monitor the status of antitrust approvals and the UK High Court sanction.
- Review the full text of the Bridge Loan Agreement (Exhibit 10.5) for specific default triggers and covenant calculations.
- Confirm the outcome of the Tate & Lyle shareholder vote required for the scheme of arrangement.
- Assess the potential for a competing bid that could trigger the lapse of irrevocable undertakings.